Renal involvement is one of the major adverse events of these drugs. It may vary from simple membranous nephropathy (Manabe S et al. 2015) to ANCA-associated aggressive nephritis and crescentic glomerulonephritis for both D-pencillamine and bucillamine (Bienaime F et al. 2007; Basterrechea MA 2004)., Read more...
For security purposes, please solve this simple puzzle to verify you are human before sending an OTP.
Want to receive push notifications for all major on-site activities?
You must be logged in to post a comment.
You must be logged in to post a comment.